There is no doubt the SP will recover from this point on as we move closer to the end of this FY given the comments around improved revenue forecast in the 4C (in particular with Abiomed orders). The question is how quick will it bounce back.
It would be useful for a trading update sometime in May to confirm that we're tracking better for this qrt. This will ensure confidence re this investment.